Pfizer Car Icahn

Pfizer – Allergan Hook Up Could Run Into "Currency" Issues

When ValueWalk first reported that Allergan PLC was planning on engaging in a more aggressive roll-up strategy, citing unnamed sources in corporate meetings and confirmed by someone with visibility into the execution strategy, the speculation quickly spread as to what company was on the acquisition menu. The facts behind the exclusive reporting was later confirmed, but what many inside the financial services industry who plot the future probability paths with a mathematical precision didn . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 10/31/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others